Old Mission Capital’s Apexigen Warrant APGNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-14,286
Closed -$2K – 1486
2022
Q2
$2K Buy
14,286
+635
+5% +$105 ﹤0.01% 1328
2022
Q1
$6K Buy
13,651
+1,014
+8% +$331 ﹤0.01% 1267
2021
Q4
$5K Buy
+12,637
New +$8.67K ﹤0.01% 1004

Other funds holding APGNW

Old Mission Capital's APGNW Position: Q3 2022 in Review

Old Mission Capital sold out of Apexigen Warrant (APGNW) in Q3 2022, closing a stake of 14,286 shares — an estimated $2K sold.

Old Mission Capital first reported a position in APGNW in Q4 2021 and held it in 3 quarters. The position peaked at $6K in Q1 2022. 16 funds tracked by Wall St. Rank hold APGNW as of Q3 2022.

  • Old Mission Capital reported no remaining Apexigen Warrant position as of Q3 2022 after selling out during the quarter.
  • Old Mission Capital sold 14,286 Apexigen Warrant shares in Q3 2022, an estimated $2K.
  • Old Mission Capital first reported a position in Apexigen Warrant in Q4 2021 and held it in 3 quarters.
  • Old Mission Capital's Apexigen Warrant position peaked at $6K in Q1 2022.
  • 16 funds tracked by Wall St. Rank held Apexigen Warrant as of Q3 2022.

Based on Old Mission Capital's 13F filing for Q3 2022, filed 14 Nov 2022.